BPMC
LPL Financial’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $803K | Sell |
6,261
-9,944
| -61% | -$1.27M | ﹤0.01% | 3905 |
|
2025
Q1 | $1.43M | Buy |
16,205
+8,248
| +104% | +$730K | ﹤0.01% | 3218 |
|
2024
Q4 | $694K | Sell |
7,957
-1,124
| -12% | -$98K | ﹤0.01% | 3764 |
|
2024
Q3 | $840K | Sell |
9,081
-152
| -2% | -$14.1K | ﹤0.01% | 3502 |
|
2024
Q2 | $995K | Sell |
9,233
-353
| -4% | -$38K | ﹤0.01% | 3220 |
|
2024
Q1 | $909K | Buy |
9,586
+216
| +2% | +$20.5K | ﹤0.01% | 3237 |
|
2023
Q4 | $864K | Sell |
9,370
-1,424
| -13% | -$131K | ﹤0.01% | 3137 |
|
2023
Q3 | $542K | Sell |
10,794
-142
| -1% | -$7.13K | ﹤0.01% | 3395 |
|
2023
Q2 | $691K | Buy |
10,936
+256
| +2% | +$16.2K | ﹤0.01% | 3141 |
|
2023
Q1 | $480K | Buy |
10,680
+2,124
| +25% | +$95.6K | ﹤0.01% | 3355 |
|
2022
Q4 | $375K | Buy |
8,556
+3,810
| +80% | +$167K | ﹤0.01% | 3478 |
|
2022
Q3 | $313K | Buy |
+4,746
| New | +$313K | ﹤0.01% | 3520 |
|
2022
Q1 | – | Sell |
-2,347
| Closed | -$251K | – | 4188 |
|
2021
Q4 | $251K | Buy |
2,347
+19
| +0.8% | +$2.03K | ﹤0.01% | 3809 |
|
2021
Q3 | $239K | Buy |
+2,328
| New | +$239K | ﹤0.01% | 3799 |
|
2021
Q2 | – | Sell |
-18,809
| Closed | -$1.83M | – | 4206 |
|
2021
Q1 | $1.83M | Buy |
18,809
+16,006
| +571% | +$1.56M | ﹤0.01% | 1905 |
|
2020
Q4 | $314K | Sell |
2,803
-581
| -17% | -$65.1K | ﹤0.01% | 3149 |
|
2020
Q3 | $314K | Buy |
3,384
+456
| +16% | +$42.3K | ﹤0.01% | 2858 |
|
2020
Q2 | $228K | Buy |
+2,928
| New | +$228K | ﹤0.01% | 3014 |
|
2020
Q1 | – | Sell |
-3,428
| Closed | -$275K | – | 3226 |
|
2019
Q4 | $275K | Buy |
3,428
+221
| +7% | +$17.7K | ﹤0.01% | 2836 |
|
2019
Q3 | $236K | Sell |
3,207
-6,603
| -67% | -$486K | ﹤0.01% | 2861 |
|
2019
Q2 | $925K | Buy |
9,810
+5,980
| +156% | +$564K | ﹤0.01% | 1772 |
|
2019
Q1 | $307K | Buy |
+3,830
| New | +$307K | ﹤0.01% | 2599 |
|
2018
Q4 | – | Sell |
-5,262
| Closed | -$411K | – | 3069 |
|
2018
Q3 | $411K | Buy |
+5,262
| New | +$411K | ﹤0.01% | 2390 |
|